195 related articles for article (PubMed ID: 19135810)
1. TNF-alpha antagonists and other recombinant proteins for the treatment of rheumatoid arthritis.
Brasington R
J Hand Surg Am; 2009 Feb; 34(2):349-50. PubMed ID: 19135810
[No Abstract] [Full Text] [Related]
2. Putting new disease-modifying antirheumatic drugs into perspective.
Saseen JJ
Pharmacotherapy; 2007 Dec; 27(12):1609-10. PubMed ID: 18041880
[No Abstract] [Full Text] [Related]
3. Rheumatoid arthritis: beyond tumor necrosis factor-alpha antagonists, B cell depletion, and T cell blockade.
Manadan AM; Block JA
Am J Ther; 2008; 15(1):53-8. PubMed ID: 18223354
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic agents for patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor-alpha antagonists.
Isaacs JD
Expert Opin Biol Ther; 2009 Dec; 9(12):1463-75. PubMed ID: 19916731
[TBL] [Abstract][Full Text] [Related]
5. Treatment, management, and monitoring of established rheumatoid arthritis.
Bingham CO; Miner MM
J Fam Pract; 2007 Oct; 56(10 Suppl Rapid):S1-7; quiz S8. PubMed ID: 17949607
[No Abstract] [Full Text] [Related]
6. Comment on: Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis.
Belmonte Serrano MA; Pincus T
Rheumatology (Oxford); 2010 Sep; 49(9):1795-6; author reply 1796-7. PubMed ID: 20484342
[No Abstract] [Full Text] [Related]
7. [Evidence-based treatment of methotrexate-resistant rheumatoid arthritis. Cytokine antagonists].
Schnabel A; Gross WL
Dtsch Med Wochenschr; 2003 Jan; 128(5):201-3. PubMed ID: 12557112
[No Abstract] [Full Text] [Related]
8. Drugs for rheumatoid arthritis.
Treat Guidel Med Lett; 2012 May; 10(117):37-44; quiz 2 p following 44. PubMed ID: 22538522
[No Abstract] [Full Text] [Related]
9. [TNF antagonists in therapy of rheumatoid arthritis].
Oberpichler-Schwenk H
Med Monatsschr Pharm; 1999 Nov; 22(11):334-9. PubMed ID: 10596266
[No Abstract] [Full Text] [Related]
10. Rheumatoid arthritis: choice of antirheumatic treatment. Methotrexate first.
Prescrire Int; 2010 Feb; 19(105):30-4. PubMed ID: 20455343
[TBL] [Abstract][Full Text] [Related]
11. Biological drug treatment of rheumatoid arthritis and spondyloarthritis: effects on QT interval and QT dispersion.
DI Franco M; Paradiso M; Ceccarelli F; Scrivo R; Spinelli FR; Iannuccelli C; Valesini G
J Rheumatol; 2012 Jan; 39(1):41-5. PubMed ID: 22045840
[TBL] [Abstract][Full Text] [Related]
12. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2011.
Furst DE; Keystone EC; Braun J; Breedveld FC; Burmester GR; De Benedetti F; Dörner T; Emery P; Fleischmann R; Gibofsky A; Kalden JR; Kavanaugh A; Kirkham B; Mease P; Sieper J; Singer NG; Smolen JS; Van Riel PL; Weisman MH; Winthrop K
Ann Rheum Dis; 2012 Apr; 71 Suppl 2():i2-45. PubMed ID: 22460137
[No Abstract] [Full Text] [Related]
13. Strategies after the failure of the first anti-tumor necrosis factor alpha agent in rheumatoid arthritis.
Papagoras C; Voulgari PV; Drosos AA
Autoimmun Rev; 2010 Jun; 9(8):574-82. PubMed ID: 20433955
[TBL] [Abstract][Full Text] [Related]
14. Rituximab and abatacept for rheumatoid arthritis.
BMJ Group
Drug Ther Bull; 2008 Aug; 46(8):57-61. PubMed ID: 18687584
[TBL] [Abstract][Full Text] [Related]
15. [TNF-alpha antibody in rheumatoid arthritis. Efficacy-risk relationship is positively evaluated].
MMW Fortschr Med; 2002 May; 144(20):65. PubMed ID: 12119893
[No Abstract] [Full Text] [Related]
16. Developing a new generation of TNFalpha antagonists for the treatment of rheumatoid arthritis.
Fleischmann R; Shealy D
Mol Interv; 2003 Sep; 3(6):310-8. PubMed ID: 14993463
[No Abstract] [Full Text] [Related]
17. Sequential use of biologic therapy in rheumatoid arthritis.
Buch MH
Curr Opin Rheumatol; 2010 May; 22(3):321-9. PubMed ID: 20190641
[TBL] [Abstract][Full Text] [Related]
18. Anti-tumor necrosis factor therapy increases synovial osteoprotegerin expression in rheumatoid arthritis.
Catrina AI; af Klint E; Ernestam S; Catrina SB; Makrygiannakis D; Botusan IR; Klareskog L; Ulfgren AK
Arthritis Rheum; 2006 Jan; 54(1):76-81. PubMed ID: 16385498
[TBL] [Abstract][Full Text] [Related]
19. Comparative overview of safety of the biologics in rheumatoid arthritis.
Khraishi M
J Rheumatol Suppl; 2009 Jun; 82():25-32. PubMed ID: 19509327
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of rheumatoid arthritis by inhibition of tumor necrosis factor with infliximab or etanercept].
Verhoeven AC; Boers M
Ned Tijdschr Geneeskd; 2001 Nov; 145(47):2294-5. PubMed ID: 11760611
[No Abstract] [Full Text] [Related]
[Next] [New Search]
